• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • First Wave BioPharma to continue Covid-19 GI infection therapy trial Pharmaceutical-Technology
    December 02, 2021
    An independent data monitoring committee (DMC) has recommended First Wave BioPharma to continue enrolment for the second part of its ongoing RESERVOIR Phase II trial of FW-COV to treat gastrointestinal (GI) infections related to Covid-19.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service